Wockhardt has received final USFDA approval for its generic prostrate cancer tablet abiraterone acetate. The drug in strength of 250mg is a generic version of […]
Wockhardt has received final USFDA approval for 100 mg and 400 mg tablets of Imatinib Mesylate to market the same in US markets. The drug […]
Wockhardt has received final USFDA approval for its generic Oxacillin injection used for the treatment of bacterial infections. The drug will be made available in […]
Wockhardt has received USFDA approval to market generic version of Wyeth’s Zosyn, used for treating bacterial infections, in the American market. Wockhardt Bio AG had […]
Copyright © 2021 | Ibis Research Information Services Pvt Ltd Privacy Policy and Terms of Use